3rd Annual Vaccines Congress 2013

150 delegates working within vaccine discovery and development, representing leading biotech companies, global pharma organisations and internationally renowned academic institutions

25 presentations, case studies and panel discussions exploring the cutting-edge innovations in vaccine discovery, vaccine development and clinical trials

2 interactive streams:

  • Vaccine Discovery and Development

  • Clinical Development and Clinical Trials

Co-located with the 6th Annual Proteins Congress and the Biosimilars & Biobetters Congress

14 pre-scheduled one to one meetings, exhibition and informal networking opportunities

Oxford Global Conferences are proud to present our 3rd Annual Vaccines Congress, taking place on the 25th & 26th March 2013 at the Novotel London West.

Experts calculate the global vaccine industry will be worth $52bn in 2016, more than double the total for 2009. The increased acceptance of adult vaccines, in conjunction with the growing focus on neglected diseases has highlighted the significant role vaccines play in the future of the pharmaceutical industry. This event will offer vital insights into the core strategies and technologies shaping the future of the vaccines industry and is a must for anyone working in the field of vaccines.

The conference programme consists of world-class keynote addresses, industry and academic led presentations and ample networking opportunities creating an interactive platform for high-level scientific and business discussions.

On Day One, our delegates will hear from those working at the forefront of vaccine discovery and development in areas including allergy vaccines, infectious diseases and tropical diseases. Our panel of experts will also discuss novel DNA and RNA based approaches to vaccine development, as well as giving invaluable insights into the latest technological advances.

On Day Two, presentations will explore the current challenges and solutions in clinical trial design, critical opportunities in the emerging markets as well as key regulatory updates. Our distinguished speakers will discuss the most important updates in adjuvant technologies, novel administration methods and vector vaccines.

The Vaccines Congress is part of the highly successful Oxford Global Biotherapeutics Series. For more information on other events in the series, please see the details below:

Proteins, Vaccines and Biosimilars & Biobetters Sponsors 2013:


Media Partners